0001209191-18-026950.txt : 20180430
0001209191-18-026950.hdr.sgml : 20180430
20180430205927
ACCESSION NUMBER: 0001209191-18-026950
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180426
FILED AS OF DATE: 20180430
DATE AS OF CHANGE: 20180430
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paul David C
CENTRAL INDEX KEY: 0001555391
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35621
FILM NUMBER: 18792715
MAIL ADDRESS:
STREET 1: C/O GLOBUS MEDICAL, INC.
STREET 2: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLOBUS MEDICAL INC
CENTRAL INDEX KEY: 0001237831
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043744954
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
BUSINESS PHONE: 610-930-1800
MAIL ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-04-26
0
0001237831
GLOBUS MEDICAL INC
GMED
0001555391
Paul David C
VALLEY FORGE BUSINESS CENTER
2560 GENERAL ARMISTEAD AVENUE
AUDUBON
PA
19403
1
1
1
0
Executive Chairman
Class A Common Stock
2018-04-26
4
M
0
18461
4.88
A
1096461
D
Class A Common Stock
2018-04-26
4
S
0
18461
51.8068
D
1078000
D
Class A Common Stock
2018-04-26
4
M
0
18461
11.8625
A
1096461
D
Class A Common Stock
2018-04-26
4
S
0
18461
51.8068
D
1078000
D
Class A Common Stock
2018-04-26
4
M
0
18461
10.66
A
1096461
D
Class A Common Stock
2018-04-26
4
S
0
18461
51.8068
D
1078000
D
Class A Common Stock
2018-04-26
4
M
0
15000
15.34
A
1093000
D
Class A Common Stock
2018-04-26
4
S
0
15000
51.8068
D
1078000
D
Class A Common Stock
2018-04-26
4
M
0
48000
13.04
A
1126000
D
Class A Common Stock
2018-04-26
4
S
0
48000
51.8068
D
1078000
D
Class A Common Stock
2018-04-26
4
M
0
60000
23.95
A
1138000
D
Class A Common Stock
2018-04-26
4
S
0
60000
51.8068
D
1078000
D
Class A Common Stock
2018-04-26
4
M
0
98958
24.10
A
1176958
D
Class A Common Stock
2018-04-26
4
S
0
98958
51.8068
D
1078000
D
Class A Common Stock
2018-04-26
4
M
0
40625
25.52
A
1118625
D
Class A Common Stock
2018-04-26
4
S
0
40625
51.8068
D
1078000
D
Class A Common Stock
2018-04-26
4
M
0
43750
26.27
A
1121750
D
Class A Common Stock
2018-04-26
4
S
0
43750
51.8068
D
1078000
D
Class A Common Stock
2018-04-26
4
S
0
363284
51.8068
D
714716
D
Class A Common Stock
2018-04-27
4
S
0
29066
51.7831
D
685650
D
Class A Common Stock
2018-04-30
4
S
0
72938
51.8053
D
612712
D
Stock Option (Right to Buy Class A Common Stock)
4.88
2018-04-26
4
M
0
18461
0.00
D
2019-08-06
Class A Common Stock
18461
0
D
Stock Option (Right to Buy Class A Common Stock)
11.8625
2018-04-26
4
M
0
18461
0.00
D
2020-06-16
Class A Common Stock
18461
0
D
Stock Option (Right to Buy Class A Common Stock)
10.66
2018-04-26
4
M
0
18461
0.00
D
2021-10-27
Class A Common Stock
18461
0
D
Stock Option (Right to Buy Class A Common Stock)
15.34
2018-04-26
4
M
0
15000
0.00
D
2022-08-29
Class A Common Stock
15000
0
D
Stock Option (Right to Buy Class A Common Stock)
13.04
2018-04-26
4
M
0
48000
0.00
D
2023-01-24
Class A Common Stock
48000
0
D
Stock Option (Right to Buy Class A Common Stock)
23.95
2018-04-26
4
M
0
60000
0.00
D
2024-01-23
Class A Common Stock
60000
0
D
Stock Option (Right to Buy Class A Common Stock)
24.10
2018-04-26
4
M
0
98958
0.00
D
2025-01-20
Class A Common Stock
98958
26042
D
Stock Option (Right to Buy Class A Common Stock)
25.52
2018-04-26
4
M
0
40625
0.00
D
2026-01-25
Class A Common Stock
40625
34375
D
Stock Option (Right to Buy Class A Common Stock)
26.27
2018-04-26
4
M
0
43750
0.00
D
2027-01-30
Class A Common Stock
43750
106250
D
This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.75 to $51.8558, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.75 to $51.935, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
These options were granted on August 6, 2009, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2010, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on June 16, 2010, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2011, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on October 27, 2011, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on August 29, 2012, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2013, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 24, 2013, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 23, 2014, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2015, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 20, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months
/s/ Eric I. Schwartz, Attorney-in-Fact
2018-04-30